JURA Bio, Inc.
Building the future of cell-based therapies.
CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive.
Cell-based Therapies and Machine Learning